Page d'accueil  |  Aide  |  Effacer
Anglais  |  Français
 Rechercher  |  Catégories  |  Titres A-Z  |  Pays  |  Comparer pays  |  Index  
Etendre sommaire
Document complet
Dérouler chapitre
Préférences

fermer ce livreDrugs Formulary for Health Center - Ethiopia (DACA; 2004; 222 pages)
Afficher le documentACKNOWLEDGEMENTS
Afficher le documentINTRODUCTION
ouvrir ce répertoire et afficher son contenuGENERAL ADVICE TO PRESCRIBERS
ouvrir ce répertoire et afficher son contenu2. CARDIOVASCULAR DRUGS
ouvrir ce répertoire et afficher son contenu3. RESPIRATORY DRUGS
ouvrir ce répertoire et afficher son contenu4. CENTRAL NERVOUS SYSTEM DRUGS
ouvrir ce répertoire et afficher son contenu5. DRUGS USED IN ANESTHESIA
fermer ce répertoire6. DRUGS USED IN MUSCULOSKELETAL AND JOINT DISEASE
Afficher le document6.1. Antirheumatics
Afficher le document6.2. Drugs used for gout
Afficher le document6.3. Skeletal Muscle Relaxants
Afficher le document6.4. Cholinergic and Anticholinesterase Agents
ouvrir ce répertoire et afficher son contenu7. ANTI-INFECTIVE
ouvrir ce répertoire et afficher son contenu8. DRUGS USED IN ENDOCRINE DISORDERS AND CONTRACEPTIVES.
Afficher le document9. OBSTETRIC AND GYNAECOLOGICAL MEDICATIONS
ouvrir ce répertoire et afficher son contenu10. BLOOD PRODUCTS AND DRUGS AFFECTING THE BLOOD
ouvrir ce répertoire et afficher son contenu11. DRUGS FOR CORRECTING WATER, ELECTROLYTE AND ACID - BASE DISTURBANCES
ouvrir ce répertoire et afficher son contenu12. VITAMINS
ouvrir ce répertoire et afficher son contenu13. ANTIHISTAMINES AND ANTIALLERGICS
ouvrir ce répertoire et afficher son contenu14. OPHTHALMIC AGENTS
ouvrir ce répertoire et afficher son contenu15. EAR, NOSE, AND THROAT PREPARATIONS
ouvrir ce répertoire et afficher son contenu16. DERMATOLOGIC AGENTS
Afficher le document17. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONING
Afficher le document18. IMMUNOLOGICAL PREPARATIONS
Afficher le document19. MISCELLANEOUS
Afficher le documentAPPENDIXES
Afficher le documentGLOSSARY
Afficher le documentADVERSE DRUG REACTION REPORTING FORM
Afficher le documentBACK COVER
 

6.3. Skeletal Muscle Relaxants

Skeletal muscle relaxants such as diazepam are indicated as adjuncts to other measures, such as rest and physical therapy, for the relief of muscle spasm associated with acute, painful musculoskeletal conditions. They act principally on the central nervous system. They differ in action from the muscle relaxants used in anaesthesia which block transmission at the neuromuscular junction.

The major disadvantage of treatment with these drugs is that reduction in muscle tone can cause a loss of splinting action of the spastic leg and trunk muscles and sometimes lead to an increase in disability

Diazepam

Tablet, 2 mg, 5 mg, 10 mg
Syrup, 2 mg/5 ml
Injection, 10 mg/ml, in 2 ml ampoule

Indications: - muscle spasm of varied aetiology, including tetanus; other indications (section 4.2, section 4.3).

Cautions: see section 4.2; special precautions for intravenous injection.

Contraindications; Side effects, see section 4.2; also hypotonia

Dose and Administrations

By mouth, 2 - 15 mg daily in divided doses, increased if necessary in spastic conditions to 60 mg daily according to response.

Cerebral spasticity in selected cases, child 2 - 40 mg daily in divided doses.

By intramuscularly or by slow intravenous injection (into a large vein at a rate of not more than 5 mg/minute), in acute muscle spasm, 10 mg repeated if necessary after 4 hours.

Note: Only use IM route when oral and IV routes not possible.


Tetanus, Adult and Child, by intravenous injection, 100 - 300 micrograms/kg repeated every 1 - 4 hours; by intravenous infusion (or by nasoduodenal tube), 3 - 10 mg/kg over 24 hours, adjusted according to response

vers la section précédentevers la section suivante

S'il vous plaît envoyez vos commentaires Anglais  |  Français